12:54 PM EST - Knight Therapeutics Inc. : Reported financial results for its second quarter ended June 30, 2017. Revenue for Q2 2017 was $2,840, an increase of $1,345 or 119% versus Q2 2016. Net income for Q2 2017 was $459, a decrease of $3,987 or 90% versus Q2 2016. Knight Therapeutics Inc.
shares T.GUD are trading up $0.15 at $8.69.
